Literature DB >> 11000132

S-nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig.

K Fang1, R Johns, T Macdonald, M Kinter, B Gaston.   

Abstract

Airway levels of the endogenous bronchodilator S-nitrosoglutathione (GSNO) are low in children with near-fatal asthma. We hypothesized that GSNO could be broken down in the lung and that this catabolism could inhibit airway smooth muscle relaxation. In our experiments, GSNO was broken down by guinea pig lung homogenates, particularly after ovalbumin sensitization (OS). Two lung protein fractions had catabolic activity. One was NADPH dependent and was more active after OS. The other was NADPH independent and was partially inhibited by aurothioglucose. Guinea pig lung tissue protein fractions with GSNO catabolic activity inhibited GSNO-mediated guinea pig tracheal ring relaxation. The relaxant effect of GSNO was partially restored by aurothioglucose. These observations suggest that catabolism of GSNO in the guinea pig 1) is mediated by lung proteins, 2) is partially upregulated after OS, and 3) may contribute to increased airway smooth muscle tone. We speculate that enzymatic breakdown of GSNO in the lung could contribute to asthma pathophysiology by inhibiting the beneficial effects of GSNO, including its effect on airway smooth muscle tone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11000132     DOI: 10.1152/ajplung.2000.279.4.L716

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  22 in total

Review 1.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

2.  Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells.

Authors:  Khalequz Zaman; Marie H Hanigan; Alison Smith; John Vaughan; Timothy Macdonald; David R Jones; John F Hunt; Benjamin Gaston
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-13       Impact factor: 6.914

3.  S-nitrosoglutathione reductase in human lung cancer.

Authors:  Nadzeya V Marozkina; Christina Wei; Sean Yemen; Horst Wallrabe; Alykhan S Nagji; Lei Liu; Tatiana Morozkina; David R Jones; Benjamin Gaston
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

Review 4.  S-Nitrosylation signaling regulates cellular protein interactions.

Authors:  Nadzeya V Marozkina; Benjamin Gaston
Journal:  Biochim Biophys Acta       Date:  2011-06-24

Review 5.  S-nitrosoglutathione.

Authors:  Katarzyna A Broniowska; Anne R Diers; Neil Hogg
Journal:  Biochim Biophys Acta       Date:  2013-02-14

6.  NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response.

Authors:  R A Dweik; S A Comhair; B Gaston; F B Thunnissen; C Farver; M J Thomassen; M Kavuru; J Hammel; H M Abu-Soud; S C Erzurum
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

7.  Human carbonyl reductase 1 is an S-nitrosoglutathione reductase.

Authors:  Raynard L Bateman; Daniel Rauh; Brandon Tavshanjian; Kevan M Shokat
Journal:  J Biol Chem       Date:  2008-09-29       Impact factor: 5.157

8.  S-nitrosoglutathione reductase: an important regulator in human asthma.

Authors:  Loretta G Que; Zhonghui Yang; Jonathan S Stamler; Njira L Lugogo; Monica Kraft
Journal:  Am J Respir Crit Care Med       Date:  2009-04-24       Impact factor: 21.405

Review 9.  Biomarkers in asthma: a real hope to better manage asthma.

Authors:  Serpil C Erzurum; Benjamin M Gaston
Journal:  Clin Chest Med       Date:  2012-07-25       Impact factor: 2.878

10.  Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation.

Authors:  Niki L Reynaert; Karina Ckless; Solange H Korn; Nanda Vos; Amy S Guala; Emiel F M Wouters; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.